Patent · US Active

Methods for treating cancer

US10646464B2 · kind B2 · utility

1Cited by
63References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 16, 2018
Grant dateMay 12, 2020
Priority date
Expiry dateMay 16, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating advanced thymoma and thymic carcinoma in a subject comprising administering and kits comprising at least one paclitaxel compound and at least one compound of formula (I) (2-acetylnaphtho[2,3-b]furan-4,9-dione) as disclosed herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.